kininogen-1 O-glycosylated 10 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-577 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P01042-1, Ser-577, MOD:00002~GNO:G17015OC.


kininogen-1 O-glycosylated 29 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-273 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-273, MOD:00005~GNO:G43417UB.


kininogen-1 N-glycosylated 4 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G27947YN.


kininogen-1 O-glycosylated 33 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-401 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-401, MOD:00005~GNO:G43417UB.


kininogen-1 O-glycosylated 44 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-542 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-542, MOD:00005~GNO:G43417UB.


kininogen-1 O-glycosylated 5 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-150 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Ser-150, MOD:00002~GNO:G53434XO.


kininogen-1 O-glycosylated 43 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-533 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Thr-533, MOD:00005~GNO:G53434XO.


kininogen-1 isoform h3 (human)

A kininogen-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01042-3.


kininogen-1 N-glycosylated 30 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G43417UB.


kininogen-1 O-glycosylated 36 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-407 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-407, MOD:00005~GNO:G43417UB.


kininogen-1 N-glycosylated 38 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-48 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P01042-1, Asn-48, MOD:00160~GNO:G88374WZ.


kininogen-1 N-glycosylated 29 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G42358LZ.


kininogen-1 O-glycosylated 8 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-531 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G73004SD. Example: UniProtKB:P01042-1, Ser-531, MOD:00002~GNO:G73004SD.


kininogen-1 N-glycosylated 27 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G36131WL.


kininogen-1 N-glycosylated 1 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G00912UN.


kininogen-1 O-glycosylated 31 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-400 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:P01042-1, Thr-400, MOD:00005~GNO:G57317CE.


kininogen-1 N-glycosylated 11 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G00912UN.


kininogen-1 O-glycosylated 27 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-151 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-151, MOD:00005~GNO:G43417UB.


kininogen-1 O-glycosylated 40 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-532 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P01042-1, Thr-532, MOD:00005~GNO:G58001LT.


kininogen-1 isoform LMW (human)

A kininogen-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01042-2.


kininogen-1 N-glycosylated 13 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G08293MJ.


kininogen-1 N-glycosylated 14 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G17015OC.


kininogen-1 O-glycosylated 28 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-273 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Thr-273, MOD:00005~GNO:G29068FM.


kininogen-1 N-glycosylated 3 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G11115RO. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G11115RO.


kininogen-1 O-glycosylated 25 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-151 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G17015OC. Example: UniProtKB:P01042-1, Thr-151, MOD:00005~GNO:G17015OC.


kininogen-1 N-glycosylated 24 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G08293MJ.


kininogen-1 O-glycosylated 18 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G29068FM.


kininogen-1 O-glycosylated 9 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-550 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Ser-550, MOD:00002~GNO:G43417UB.


kininogen-1 O-glycosylated 45 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-542 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Thr-542, MOD:00005~GNO:G53434XO.


kininogen-1 O-glycosylated 17 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G23729WG. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G23729WG.


kininogen-1 O-glycosylated 46 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-546 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Thr-546, MOD:00005~GNO:G29068FM.


kininogen-1 O-glycosylated 15 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-604 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Ser-604, MOD:00002~GNO:G43417UB.


kininogen-1 isoform HMW (human)

A kininogen-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P01042-1.


kininogen-1 O-glycosylated 1 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-120 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Ser-120, MOD:00002~GNO:G53434XO.


kininogen-1 O-glycosylated 35 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-401 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P01042-1, Thr-401, MOD:00005~GNO:G58001LT.


kininogen-1 N-glycosylated 17 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G59626AS.


kininogen-1 N-glycosylated 6 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G59626AS.


kininogen-1 O-glycosylated 7 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-408 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Ser-408, MOD:00002~GNO:G43417UB.


kininogen-1 O-glycosylated 26 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-151 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Thr-151, MOD:00005~GNO:G29068FM.


kininogen-1 O-glycosylated 39 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-532 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Thr-532, MOD:00005~GNO:G53434XO.


kininogen-1 N-glycosylated 10 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G99679NM. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G99679NM.


kininogen-1 N-glycosylated 32 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G59626AS.


kininogen-1 N-glycosylated 2 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G06247RL.


kininogen-1 N-glycosylated 26 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G27947YN.


kininogen-1 O-glycosylated 49 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-571 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G23729WG. Example: UniProtKB:P01042-1, Thr-571, MOD:00005~GNO:G23729WG.


kininogen-1 N-glycosylated 15 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G27947YN.


kininogen-1 O-glycosylated 21 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G57317CE. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G57317CE.


kininogen-1 O-glycosylated 13 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-604 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G23729WG. Example: UniProtKB:P01042-1, Ser-604, MOD:00002~GNO:G23729WG.


kininogen-1 N-glycosylated 23 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G06247RL.


kininogen-1 O-glycosylated 38 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-532 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-532, MOD:00005~GNO:G43417UB.


kininogen-1 N-glycosylated 8 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G94917XT.


kininogen-1 O-glycosylated 20 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G53434XO.


kininogen-1 O-glycosylated 47 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-546 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-546, MOD:00005~GNO:G43417UB.


kininogen-1 O-glycosylated 19 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G43417UB.


kininogen-1 O-glycosylated 41 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-533 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Thr-533, MOD:00005~GNO:G29068FM.


kininogen-1 O-glycosylated 24 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G95678HJ. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G95678HJ.


kininogen-1 O-glycosylated 37 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-407 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Thr-407, MOD:00005~GNO:G53434XO.


kininogen-1 O-glycosylated 32 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-401 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01042-1, Thr-401, MOD:00005~GNO:G06247RL.


kininogen-1 N-glycosylated 5 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G29068FM.


kininogen-1 O-glycosylated 3 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-150 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P01042-1, Ser-150, MOD:00002~GNO:G27947YN.


kininogen-1 O-glycosylated 11 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-599 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Ser-599, MOD:00002~GNO:G43417UB.


kininogen-1 O-glycosylated 14 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-604 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:P01042-1, Ser-604, MOD:00002~GNO:G29068FM.


kininogen-1 N-glycosylated 21 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G94917XT.


kininogen-1, signal peptide removed form (human)

A kininogen-1 (human) that has had the signal peptide removed. UniProtKB:P01042, 19-644.


kininogen-1 O-glycosylated 34 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-401 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Thr-401, MOD:00005~GNO:G53434XO.


kininogen-1 N-glycosylated 25 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G10486CT.


kininogen-1 N-glycosylated 18 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G85144OK.


kininogen-1 N-glycosylated 36 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-48 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P01042-1, Asn-48, MOD:00160~GNO:G06247RL.


kininogen-1 N-glycosylated 7 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G85144OK.


kininogen-1 N-glycosylated 35 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-48 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01042-1, Asn-48, MOD:00160~GNO:G00912UN.


kininogen-1 N-glycosylated 9 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-169 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G95678HJ. Example: UniProtKB:P01042-1, Asn-169, MOD:00160~GNO:G95678HJ.


kininogen-1 O-glycosylated 23 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-137 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01042-1, Thr-137, MOD:00005~GNO:G94917XT.


kininogen-1 O-glycosylated 12 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-599 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G53434XO. Example: UniProtKB:P01042-1, Ser-599, MOD:00002~GNO:G53434XO.


kininogen-1 N-glycosylated 33 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G85144OK.


kininogen-1 N-glycosylated 31 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G58001LT. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G58001LT.


kininogen-1 O-glycosylated 42 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Thr-533 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Thr-533, MOD:00005~GNO:G43417UB.


kininogen-1 N-glycosylated 22 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G00912UN.


kininogen-1 N-glycosylated 19 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G86752LQ. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G86752LQ.


kininogen-1 N-glycosylated 20 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-205 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P01042-1, Asn-205, MOD:00160~GNO:G88374WZ.


kininogen-1 O-glycosylated 4 (human)

A kininogen-1 (human) that has been O-glycosylated at the residue equivalent to Ser-150 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P01042-1, Ser-150, MOD:00002~GNO:G43417UB.


kininogen-1 N-glycosylated 28 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G40926MX.


kininogen-1 N-glycosylated 34 (human)

A kininogen-1 (human) that has been N-glycosylated at the residue equivalent to Asn-294 of the amino acid sequence represented by UniProtKB:P01042-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P01042-1, Asn-294, MOD:00160~GNO:G94917XT.


versican core protein, signal peptide removed form (human)

A versican core protein (human) that has had the signal peptide removed. UniProtKB:P13611, 21-3396.


parathyroid hormone/parathyroid hormone-related peptide receptor

A parathyroid hormone receptor that is a translation product of the human PTH1R gene or a 1:1 ortholog thereof.


parathyroid hormone receptor

A secretin-like G-protein coupled receptor that is a translation product of the human PTH1R or PTH2R genes, 1:1 orthologs thereof, or a semi-ortholog thereof.


parathyroid hormone 2 receptor

A parathyroid hormone receptor that is a translation product of the human PTH2R gene or a 1:1 ortholog thereof.


parathyroid hormone 2 receptor, signal peptide removed form (human)

A parathyroid hormone 2 receptor (human) that has had the signal peptide removed. UniProtKB:P49190, 25-550.


parathyroid hormone/parathyroid hormone-related peptide receptor, signal peptide removed form (human)

A parathyroid hormone/parathyroid hormone-related peptide receptor (human) that has had the signal peptide removed. UniProtKB:Q03431, 27-593.


signal recognition particle subunit SRP72

A protein that is a translation product of the human SRP72 gene or a 1:1 ortholog thereof.


signal recognition particle subunit SRP72 isoform h1 (human)

A signal recognition particle subunit SRP72 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O76094-1.


signal recognition particle subunit SRP72 isoform h2 (human)

A signal recognition particle subunit SRP72 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O76094-2.


adhesion G-protein coupled receptor D1 isoform h1 (human)

An adhesion G-protein coupled receptor D1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6QNK2-1.


protein-DNA covalent cross-linking via peptidyl-serine

biolink:BiologicalProcess biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

The formation of a covalent cross-link between DNA and a peptidyl-serine residue by the formation of O-(phospho-5'-DNA)-L-serine.


positive regulation of triglyceride metabolic process

Any process that increases the frequency, rate or extent of the chemical reactions and pathways involving triglyceride, any triester of glycerol.


lysophospholipase D GDPD3 isoform h1 (human)

A lysophospholipase D GDPD3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7L5L3-2.


clathrin coat of endocytic vesicle

biolink:CellularComponent biolink:AnatomicalEntity biolink:OrganismalEntity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:PhysicalEssence biolink:SubjectOfInvestigation biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

A clathrin coat found on an endocytic vesicle.


roundabout homolog 1 isoform h1 (human)

A roundabout homolog 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y6N7-1.


high affinity immunoglobulin gamma Fc receptor I isoform h2 (human)

A high affinity immunoglobulin gamma Fc receptor I (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P12314-2.


EP1 subtype prostaglandin E2 receptor binding

biolink:MolecularActivity biolink:BiologicalProcessOrActivity biolink:BiologicalEntity biolink:NamedThing biolink:Entity biolink:Occurrent biolink:OntologyClass biolink:ThingWithTaxon biolink:PhysicalEssenceOrOccurrent

Binding to an EP1 subtype prostaglandin E2 receptor.


olfactory receptor 10G2

A class II olfactory receptor that is a translation product of the human OR10G2 gene or a 1:1 ortholog thereof.


positive regulation of complement activation, classical pathway in another organism

Any process that activates or increases the frequency, rate or extent of complement activation by the classical pathway, in a different organism.


ankyrin repeat and SOCS box protein 16 isoform 1 (human)

An ankyrin repeat and SOCS box protein 16 isoform 1 that is encoded in the genome of human.


Catalysis of the reaction: beta-cyclopiazonate + A = alpha-cyclopiazonate + AH(2).


cellular response to interleukin-9

Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-9 stimulus.


cyclin-dependent kinase inhibitor 1C isoform Long (human)

A cyclin-dependent kinase inhibitor 1C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P49918-1.


cyclin-dependent kinase inhibitor 1C isoform Short (human)

A cyclin-dependent kinase inhibitor 1C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P49918-2.


eukaryotic translation initiation factor 4E-binding protein 1 isoform 1 phosphorylated 1 (human)

A eukaryotic translation initiation factor 4E-binding protein 1 isoform 1 phosphorylated 1 in human. UniProtKB:Q13541-1, 2-118, Thr-37/Thr-46, MOD:00047.


eukaryotic translation initiation factor 4E-binding protein 1 isoform 1 (human)

A eukaryotic translation initiation factor 4E-binding protein 1 isoform 1 that is encoded in the genome of human.


protein spinster homolog 3

A protein that is a translation product of the human SPNS3 gene or a 1:1 ortholog thereof.


protein spinster homolog 3 isoform h2 (human)

A protein spinster homolog 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZMD2-2.


protein spinster homolog 3 isoform h1 (human)

A protein spinster homolog 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6ZMD2-1.


prosaposin N-glycosylated 94 (human)

A prosaposin (human) that has been N-glycosylated at the residue equivalent to Asn-80 of the amino acid sequence represented by UniProtKB:P07602-1, in which the glycan structure is represented by GlyTouCan:G82348BZ. Example: UniProtKB:P07602-1, Asn-80, MOD:00160~GNO:G82348BZ.


transcription initiation factor TFIID subunit 8 isoform h1 (human)

A transcription initiation factor TFIID subunit 8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q7Z7C8-1.


selenocystathione synthase activity

Catalysis of the reaction: L-selenocysteine + O-phosphonato-L-homoserine = hydrogenphosphate + L-selenocystathionine.


kinesin-like protein KIF3B isoform 1 (human)

A kinesin-like protein KIF3B isoform 1 that is encoded in the genome of human.


kinesin-like protein KIF3B isoform h2 (human)

A kinesin-like protein KIF3B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O15066-2.


transmembrane protein 182 isoform 1 (human)

A transmembrane protein 182 isoform 1 that is encoded in the genome of human.


sorbin and SH3 domain-containing protein 2 isoform h11 (human)

A sorbin and SH3 domain-containing protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O94875-11.


extracellular serine/threonine protein kinase FAM20C isoform h1 (human)

An extracellular serine/threonine protein kinase FAM20C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8IXL6-1.


collagen alpha-6(IV) chain, signal peptide removed 5-hydroxy-lysine and 4-hydroxy-proline form (human)

A collagen alpha-6(IV) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine and at least one 4-hydroxy-proline. UniProtKB:Q14031, 23-1691, MOD:00037|MOD:00039.


collagen alpha-6(IV) chain, signal peptide removed 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

A collagen alpha-6(IV) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:Q14031, 23-1691, MOD:00037|MOD:00038|MOD:00039.


complement factor H N-glycosylated 52 (human)

A complement factor H (human) that has been N-glycosylated at the residue equivalent to Asn-911 of the amino acid sequence represented by UniProtKB:P08603-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P08603-1, Asn-911, MOD:00160~GNO:G42358LZ.


specification of metanephric connecting tubule identity

The process in which the connecting tubule of the metanephric nephron acquires its identity.


guanine nucleotide exchange protein SMCR8

A protein that is a translation product of the human SMCR8 gene or a 1:1 ortholog thereof.


guanine nucleotide exchange protein SMCR8 isoform h1 (human)

A guanine nucleotide exchange protein SMCR8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TEV9-1.


guanine nucleotide exchange protein SMCR8 isoform h2 (human)

A guanine nucleotide exchange protein SMCR8 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8TEV9-2.


microfibrillar-associated protein 3-like phosphorylated 1 (human)

A microfibrillar-associated protein 3-like (human) that has been phosphorylated on the residue at the position equivalent to Tyr-287 of the amino acid sequence represented by UniProtKB:O75121-1. Example: UniProtKB:O75121-1, Tyr-287, MOD:00048.


microfibrillar-associated protein 3-like isoform h3 (human)

A microfibrillar-associated protein 3-like (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75121-3.


microfibrillar-associated protein 3-like isoform h2 (human)

A microfibrillar-associated protein 3-like (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75121-2.


microfibrillar-associated protein 3-like isoform 1 (human)

A microfibrillar-associated protein 3-like isoform 1 that is encoded in the genome of human.


adenylosuccinate lyase isoform h1 (human)

An adenylosuccinate lyase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P30566-1.


alpha-endosulfine, initiator methionine removed phosphorylated 2 (human)

An alpha-endosulfine (human) that has had the initiator methionine removed and has been post-translationally modified to include phosphoserine at position 67 of the amino acid sequence represented by UniProtKB:O43768. UniProtKB:O43768, 2-121, Ser-67, MOD:00046.


A contactin that is a translation product of the human CNTN3 gene or a 1:1 ortholog thereof.


contactin-3 isoform 1 (human)

A contactin-3 isoform 1 that is encoded in the genome of human.


phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha

A protein that is a translation product of the human PIK3C2A gene or a 1:1 ortholog thereof.


phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha isoform h2 (human)

A phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O00443-2.


phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha, initiator methionine removed form (human)

A phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (human) that has had the initiator methionine removed. UniProtKB:O00443, 2-1686.


phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha isoform h1 (human)

A phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O00443-1.


lysosome-associated membrane glycoprotein 1 N-glycosylated 26 (human)

A lysosome-associated membrane glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-249 of the amino acid sequence represented by UniProtKB:P11279-1, in which the glycan composition is represented by GlyTouCan:G40664HB. Example: UniProtKB:P11279-1, Asn-249, MOD:00160~GNO:G40664HB.


plasma protease C1 inhibitor N-glycosylated 14 (human)

A plasma protease C1 inhibitor (human) that has been N-glycosylated at the residue equivalent to Asn-25 of the amino acid sequence represented by UniProtKB:P05155-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P05155-1, Asn-25, MOD:00160~GNO:G43417UB.


cellular detoxification of acetone

Any process carried out at the cellular level that reduces or removes the toxicity of acetone. These may include chemical modification, for example to methylglyoxal.


chymotrypsin-like elastase family member 3B N-glycosylated 15 (human)

A chymotrypsin-like elastase family member 3B (human) that has been N-glycosylated at the residue equivalent to Asn-114 of the amino acid sequence represented by UniProtKB:P08861-1, in which the glycan structure is represented by GlyTouCan:G71367OV. Example: UniProtKB:P08861-1, Asn-114, MOD:00160~GNO:G71367OV.


protein ZNF365 isoform 2 (human)

A ZNF365 gene translation product (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q70YC5-2.


negative regulation of lysosomal membrane permeability

Any process that decreases the frequency, rate or extent of the passage or uptake of molecules by the lysosomal membrane.


brain-specific angiogenesis inhibitor 1-associated protein 2 isoform h5 (human)

A brain-specific angiogenesis inhibitor 1-associated protein 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UQB8-5.


complement component C7

A protein that is a translation product of the human C7 gene or a 1:1 ortholog thereof.


complement component C7, signal peptide removed form (human)

A complement component C7 (human) that has had the signal peptide removed. UniProtKB:P10643, 23-843.


complement component C7 N-glycosylated 1 (human)

A complement component C7 (human) that has been N-glycosylated at the residue equivalent to Asn-754 of the amino acid sequence represented by UniProtKB:P10643-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P10643-1, Asn-754, MOD:00160~GNO:G00912UN.


complement component C7 O-glycosylated 1 (human)

A complement component C7 (human) that has been O-glycosylated at the residue equivalent to Thr-696 of the amino acid sequence represented by UniProtKB:P10643-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P10643-1, Thr-696, MOD:00005~GNO:G43417UB.


positive regulation of butyryl-CoA catabolic process to butanol

Any process that activates or increases the frequency, rate or extent of butyryl-CoA catabolic process to butanol.


regulation of butyryl-CoA catabolic process to butanol

Any process that modulates the frequency, rate or extent of butyryl-CoA catabolic process to butanol.


negative regulation of butyryl-CoA catabolic process to butanol

Any process that stops, prevents or reduces the frequency, rate or extent of butyryl-CoA catabolic process to butanol.


protein GOLM2 O-glycosylated 5 (human)

A protein GOLM2 (human) that has been O-glycosylated at the residue equivalent to Ser-313 of the amino acid sequence represented by UniProtKB:Q6P4E1-4, in which the glycan composition is represented by GlyTouCan:G29068FM. Example: UniProtKB:Q6P4E1-4, Ser-313, MOD:00002~GNO:G29068FM.


Ras GTPase-activating protein 3 isoform 1 (human)

A Ras GTPase-activating protein 3 isoform 1 that is encoded in the genome of human.


urate catabolic process

The chemical reactions and pathways resulting in the breakdown of urate, the anion of uric acid, 2,6,8-trioxypurine.


A frizzled-like G-protein coupled receptor that is a translation product of the human FZD8 gene or a 1:1 ortholog thereof.


frizzled-8, signal peptide removed ubiquitinated form (human)

A frizzled-8 (human) that has had the signal peptide removed and that includes at least one ubiquitinated lysine. UniProtKB:Q9H461, 28-694, MOD:01148.


frizzled-8, signal peptide removed form (human)

A frizzled-8 (human) that has had the signal peptide removed. UniProtKB:Q9H461, 28-694.


sulfate transporter isoform 1 (human)

A sulfate transporter isoform 1 that is encoded in the genome of human.


microtubule-associated protein tau isoform Tau-F phosphorylated 1 (human)

A microtubule-associated protein tau isoform Tau-F phosphorylated 1 in human. UniProtKB:P10636-8, Thr-181, MOD:00047.


regulation of peripheral T cell tolerance induction

Any process that modulates the frequency, rate, or extent of peripheral T cell tolerance induction.


regulation of T cell tolerance induction to tumor cell

Any process that modulates the frequency, rate, or extent of T cell tolerance induction to tumor cell.


negative regulation of T cell tolerance induction to tumor cell

Any process that stops, prevents, or reduces the frequency, rate, or extent of T cell tolerance induction to tumor cell.


positive regulation of T cell tolerance induction to tumor cell

Any process that activates or increases the frequency, rate, or extent of T cell tolerance induction to tumor cell.


negative regulation of peripheral T cell tolerance induction

Any process that stops, prevents, or reduces the frequency, rate, or extent of peripheral T cell tolerance induction.


protein FAM171B isoform h2 (human)

A protein FAM171B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6P995-2.


non-motile cilium membrane

The portion of the plasma membrane surrounding a non-motile cilium.


cone photoreceptor disc membrane

Stack of disc membranes located inside a cone photoreceptor outer segment, and containing densely packed molecules of opsin photoreceptor proteins that traverse the lipid bilayer. Cone disc membranes arise as evaginations of the ciliary membrane during the development of the cone outer segment and remain contiguous with the ciliary membrane.


negative regulation of asperfuranone biosynthetic process

Any process that stops, prevents or reduces the frequency, rate or extent of asperfuranone biosynthetic process.


A process that results in the assembly, arrangement of constituent parts, or disassembly of a postsynaptic specialization, a structure that lies adjacent to the cytoplasmic face of the postsynaptic membrane.


protein HEXIM1

A protein that is a translation product of the human HEXIM1 gene or a 1:1 ortholog thereof.


versican core protein O-glycosylated 155 (human)

A versican core protein (human) that has been O-glycosylated at the residue equivalent to Thr-2135 of the amino acid sequence represented by UniProtKB:P13611-1, in which the glycan composition is represented by GlyTouCan:G43417UB. Example: UniProtKB:P13611-1, Thr-2135, MOD:00005~GNO:G43417UB.


Catalysis of the reaction: genistin + UDP-alpha-D-glucose <=> genistin 7-gentiobioside + UDP + H+.


abducens nerve structural organization

The process that contributes to the act of creating the structural organization of the abducens nerve. This process pertains to the physical shaping of a rudimentary structure. The motor function of the abducens nerve is to contract the lateral rectus which results in abduction of the eye.


iron-sulfur clusters transporter ABCB7, mitochondrial isoform h2 (human)

An iron-sulfur clusters transporter ABCB7, mitochondrial (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O75027-2.


protein O-mannosyl-transferase TMTC2 isoform 1 (human)

A protein O-mannosyl-transferase TMTC2 isoform 1 that is encoded in the genome of human.


C-C motif chemokine 26

A C/C-C motif small inducible chemokine that is a translation product of the human CCL26 gene or a 1:1 ortholog thereof.


single cytosine insertion binding

Binding to a double-stranded DNA region containing a single cytosine insertion or a deletion that results in an unpaired cytosine.


transcriptional activator Myb phosphorylated 1 (human)

A transcriptional activator Myb (human) that has been phosphorylated on the residue at the position equivalent to Ser-532 of the amino acid sequence represented by UniProtKB:P10242-1. Example: UniProtKB:P10242-1, Ser-532, MOD:00046.


NAD-independent histone deacetylase activity

Catalysis of the reaction: histone N6-acetyl-L-lysine + H2O = histone L-lysine + acetate. This reaction does not require the presence of NAD, and represents the removal of an acetyl group from a histone.


synaptotagmin-like protein 3 isoform h2 (human)

A synaptotagmin-like protein 3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q4VX76-2.


TGF-beta 2 isoform A cleaved 1 (human)

A TGF-beta 2 isoform A cleaved 1 in human. UniProtKB:P61812-1, 303-414.


transforming growth factor beta-2 isoform A (human)

A TGF-beta 2 isoform A that is encoded in the genome of human.


TGF-beta 2 isoform A cleaved 3 (human)

A TGF-beta 2 isoform A cleaved 3 in human, in which the cleaved parts remain joined by disulfide bonds. UniProtKB:P61812-1, 20-302, 303-414.


TGF-beta 2 isoform A cleaved 2 (human)

A TGF-beta 2 isoform A cleaved 2 in human. UniProtKB:P61812-1, 20-302.


negative regulation of lung goblet cell differentiation

Any process that stops, prevents or reduces the frequency, rate or extent of lung goblet cell differentiation.


positive regulation of protein localization to medial cortex

Any process that activates or increases the frequency, rate or extent of protein localization to the medial cortex.


regulation of protein localization to cell division site

Any process that modulates the frequency, rate or extent of protein localization to cell division site.


regulation of protein localization to cell division site involved in cell separation after cytokinesis

Any regulation of protein localization to cell division site that is involved in cell separation after cytokinesis.


positive regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly

Any process that activates or increases the frequency, rate or extent of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly.


negative regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly

Any process that stops, prevents, or reduces the frequency, rate or extent of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly.


positive regulation of protein localization to medial cortical node

Any process that activates or increases the frequency, rate or extent of protein localization to a medial cortical node.


regulation of protein localization to cell division site involved in cytokinesis

Any regulation of protein localization to cell division site that is involved in cytokinesis.


regulation of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly

Any process that modulates the frequency, rate or extent of protein localization to cell division site involved in mitotic actomyosin contractile ring assembly.


regulation of protein localization to medial cortical node

Any process that modulates the frequency, rate or extent of protein localization to a medial cortical node.


negative regulation of protein localization to medial cortex

Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to the medial cortex.


regulation of protein localization to medial cortex

Any process that regulates the localization of a protein to the medial cortex.


vascular endothelial growth factor receptor 1 N-glycosylated 4 (human)

A vascular endothelial growth factor receptor 1 (human) that has been N-glycosylated at the residue equivalent to Asn-625 of the amino acid sequence represented by UniProtKB:P17948-1, in which the glycan composition is represented by GlyTouCan:G57776ZU. Example: UniProtKB:P17948-1, Asn-625, MOD:00160~GNO:G57776ZU.


inositol-tetrakisphosphate 1-kinase isoform h2 (human)

An inositol-tetrakisphosphate 1-kinase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13572-2.


inositol-tetrakisphosphate 1-kinase isoform h1 (human)

An inositol-tetrakisphosphate 1-kinase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q13572-1.


protein Mpv17

A protein that is a translation product of the human MPV17 gene or a 1:1 ortholog thereof.


protein Mpv17 isoform 1 (human)

A protein Mpv17 isoform 1 that is encoded in the genome of human.


endosomal/lysosomal proton channel TMEM175 isoform h2 (human)

An endosomal/lysosomal proton channel TMEM175 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9BSA9-2.


solute carrier family 12 member 5 isoform h1 (human)

A solute carrier family 12 member 5 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9H2X9-1.


regulation of salicylic acid biosynthetic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of salicylic acid.


regulation of salicylic acid metabolic process

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving salicylic acid.


anthrax toxin receptor-like

A protein that is a translation product of the human ANTXRL gene or a 1:1 ortholog thereof.


glutamine-dependent NAD(+) synthetase isoform h2 (human)

A glutamine-dependent NAD(+) synthetase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6IA69-2.


glutamine-dependent NAD(+) synthetase isoform h1 (human)

A glutamine-dependent NAD(+) synthetase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6IA69-1.


structural maintenance of chromosomes protein 1B

A protein that is a translation product of the human SMC1B gene or a 1:1 ortholog thereof.


structural maintenance of chromosomes protein 1B isoform h2 (human)

A structural maintenance of chromosomes protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NDV3-2.


structural maintenance of chromosomes protein 1B isoform h3 (human)

A structural maintenance of chromosomes protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NDV3-3.


structural maintenance of chromosomes protein 1B isoform h1 (human)

A structural maintenance of chromosomes protein 1B (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NDV3-1.


collagen alpha-4(IV) chain, signal peptide removed 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

A collagen alpha-4(IV) chain (human) that has had the signal peptide removed and that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P53420, 39-1690, MOD:00037|MOD:00038|MOD:00039.


collagen alpha-4(IV) chain 5-hydroxy-lysine, 3-hydroxy-proline and 4-hydroxy-proline form (human)

A collagen alpha-4(IV) chain (human) that includes at least one 5-hydroxy-lysine, at least one 3-hydroxy-proline and at least one 4-hydroxy-proline. UniProtKB:P53420, MOD:00037|MOD:00038|MOD:00039.


bone sialoprotein 2, signal peptide removed form (human)

A bone sialoprotein 2 (human) that has had the signal peptide removed. UniProtKB:P21815, 17-317.


deoxyribonucleoside monophosphate metabolic process

The chemical reactions and pathways involving a deoxyribonucleoside monophosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with phosphate on the sugar.


purine nucleoside monophosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.


pyrimidine nucleoside monophosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine nucleoside monophosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.


purine nucleoside bisphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


deoxyribonucleoside diphosphate metabolic process

The chemical reactions and pathways involving a deoxyribonucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with diphosphate on the sugar.


pyrimidine deoxyribonucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine deoxynucleoside monophosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with phosphate on the sugar.


purine ribonucleotide salvage

Any process which produces a purine ribonucleotide from derivatives of it, without de novo synthesis.


purine deoxyribonucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine deoxyribonucleoside diphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with diphosphate on the sugar.


CMP metabolic process

The chemical reactions and pathways involving CMP, cytidine monophosphate.


pyrimidine ribonucleotide metabolic process

The chemical reactions and pathways involving a pyrimidine ribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


ribonucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.


purine ribonucleoside bisphosphate metabolic process

The chemical reactions and pathways involving a purine ribonucleoside bisphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


UMP metabolic process

The chemical reactions and pathways involving UMP, uridine monophosphate.


purine ribonucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine ribonucleoside diphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with diphosphate on the sugar.


diadenosine polyphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of diadenosine polyphosphate, a derivative of the nucleoside adenosine with phosphate groups attached.


deoxyribonucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a deoxyribonucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with diphosphate on the sugar.


purine nucleoside triphosphate metabolic process

The chemical reactions and pathways involving purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.


diadenosine triphosphate metabolic process

The chemical reactions and pathways involving diadenosine triphosphate, a derivative of the nucleoside adenosine with three phosphate groups attached.


purine deoxyribonucleoside triphosphate metabolic process

The chemical reactions and pathways involving purine deoxyribonucleoside triphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.


pyrimidine ribonucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine ribonucleoside monophosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with phosphate on the sugar.


bis(molybdopterin guanine dinucleotide)molybdenum biosynthetic process

The chemical reactions and pathways resulting in the formation of bis(molybdopterin guanine dinucleotide)molybdenum.


pyrimidine ribonucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine ribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with triphosphate on the sugar.


nicotinate nucleotide biosynthetic process

The chemical reactions and pathways resulting in the formation of nicotinamide nucleotides, any nucleotide that contains combined nicotinate (pyridine 3-carboxylic acid).


flavin adenine dinucleotide metabolic process

The chemical reactions and pathways involving flavin adenine dinucleotide, which acts as a coenzyme or prosthetic group of various flavoprotein oxidoreductase enzymes.


purine deoxyribonucleotide catabolic process

The chemical reactions and pathways resulting in the breakdown of purine deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a purine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


pyrimidine ribonucleoside diphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine ribonucleoside diphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with diphosphate on the sugar.


purine deoxyribonucleotide metabolic process

The chemical reactions and pathways involving purine deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a purine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


purine nucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.


pyrimidine deoxyribonucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine deoxyribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.


The chemical reactions and pathways involving a 2'-deoxyribonucleotide, a compound consisting of 2'-deoxyribonucleoside (a base linked to a 2'-deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


bis(5'-nucleosidyl) oligophosphate metabolic process

The chemical reactions and pathways involving a bis(5'-nucleosidyl) oligophosphate, a compound formed of two nucleosides joined together through their 5' carbons by a chain of phosphate molecules.


pyridine nucleotide biosynthetic process

The chemical reactions and pathways resulting in the formation of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.


diadenosine triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of diadenosine triphosphate, a derivative of the nucleoside adenosine with three phosphate groups attached.


purine ribonucleotide interconversion

The chemical reactions and pathways by which a purine ribonucleotide is synthesized from another purine ribonucleotide.


purine nucleoside diphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine nucleoside diphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.


pyrimidine nucleoside diphosphate metabolic process

The chemical reactions and pathways involving pyrimidine nucleoside diphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.


deoxyribonucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a deoxyribonucleoside triphosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with triphosphate on the sugar.


The chemical reactions and pathways by which a pyrimidine deoxyribonucleotide is synthesized from another pyrimidine deoxyribonucleotide.


ribonucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.


purine ribonucleotide metabolic process

The chemical reactions and pathways involving a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


pyrimidine ribonucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine ribonucleoside diphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with diphosphate on the sugar.


ribonucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.


pyrimidine ribonucleoside monophosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine ribonucleoside monophosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with phosphate on the sugar.


bis(molybdopterin guanine dinucleotide)molybdenum metabolic process

The chemical reactions and pathways involving bis(molybdopterin guanine dinucleotide)molybdenum.


CMP phosphorylation

The process of introducing a phosphate group into CMP, cytidine monophosphate, to produce CDP. Addition of two phosphate groups produces CTP.


purine deoxyribonucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine deoxyribonucleoside triphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.


pyrimidine nucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine nucleoside monophosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.


diadenosine polyphosphate metabolic process

The chemical reactions and pathways involving diadenosine polyphosphate, a derivative of the nucleoside adenosine with phosphate groups attached.


purine nucleoside diphosphate metabolic process

The chemical reactions and pathways involving purine nucleoside diphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.


ribonucleoside triphosphate metabolic process

The chemical reactions and pathways involving a ribonucleoside triphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with triphosphate on the sugar.


purine nucleoside bisphosphate metabolic process

The chemical reactions and pathways involving a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


bis(5'-nucleosidyl) oligophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a bis(5'-nucleosidyl) oligophosphate, a compound formed of two nucleosides joined together through their 5' carbons by a chain of phosphate molecules.


pyrimidine nucleotide interconversion

The chemical reactions and pathways by which a pyrimidine nucleotide is synthesized from another pyrimidine nucleotide.


AMP phosphorylation

The process of introducing a phosphate group into AMP, adenosine monophosphate, to produce ADP. Addition of two phosphate groups produces ATP.


'de novo' NAD biosynthetic process from aspartate

The chemical reactions and pathways resulting in the formation of nicotinamide adenine dinucleotide (NAD), beginning with the synthesis of aspartate from simpler precursors; biosynthesis may be of either the oxidized form, NAD, or the reduced form, NADH.


diadenosine pentaphosphate metabolic process

The chemical reactions and pathways involving diadenosine pentaphosphate.


ribonucleotide biosynthetic process

The chemical reactions and pathways resulting in the formation of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


purine deoxyribonucleoside diphosphate metabolic process

The chemical reactions and pathways involving purine deoxyribonucleoside diphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with diphosphate on the sugar.


purine ribonucleoside bisphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a purine ribonucleoside bisphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


pyrimidine nucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine nucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.


purine nucleotide interconversion

The chemical reactions and pathways by which a purine nucleotide is synthesized from another purine nucleotide.


nicotinate nucleotide metabolic process

The chemical reactions and pathways involving nicotinamide nucleotides, any nucleotide that contains combined nicotinate (pyridine 3-carboxylic acid, or niacin).


ribonucleotide catabolic process

The chemical reactions and pathways resulting in the breakdown of a ribonucleotide, a compound consisting of ribonucleoside (a base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


purine nucleoside monophosphate metabolic process

The chemical reactions and pathways involving purine nucleoside monophosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.


pyrimidine deoxyribonucleoside monophosphate metabolic process

The chemical reactions and pathways involving pyrimidine deoxynucleoside monophosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with phosphate on the sugar.


purine ribonucleoside bisphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a purine ribonucleoside bisphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


pyrimidine deoxyribonucleoside triphosphate metabolic process

The chemical reactions and pathways involving pyrimidine deoxyribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.


pyrimidine nucleoside triphosphate metabolic process

The chemical reactions and pathways involving pyrimidine nucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.


pyrimidine nucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine nucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.


pyrimidine nucleotide catabolic process

The chemical reactions and pathways resulting in the breakdown of a pyrimidine nucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


purine deoxyribonucleoside diphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine deoxyribonucleoside diphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with diphosphate on the sugar.


nucleoside bisphosphate metabolic process

The chemical reactions and pathways involving a nucleoside bisphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


purine deoxyribonucleoside monophosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine deoxyribonucleoside monophosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with phosphate on the sugar.


CMP salvage

Any process that generates CMP, cytidine monophosphate, from derivatives of it without de novo synthesis.


pyrimidine ribonucleoside monophosphate metabolic process

The chemical reactions and pathways involving pyrimidine ribonucleoside monophosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with phosphate on the sugar.


pyrimidine ribonucleoside triphosphate metabolic process

The chemical reactions and pathways involving pyrimidine ribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with triphosphate on the sugar.


ribonucleoside bisphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


nucleoside bisphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a nucleoside bisphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


purine nucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine nucleoside diphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.


pyridine nucleotide metabolic process

The chemical reactions and pathways involving a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.


purine ribonucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.


nicotinate nucleotide salvage

The generation of nicotinate nucleotide without de novo synthesis.


diadenosine tetraphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of diadenosine tetraphosphate, a derivative of the nucleoside adenosine with four phosphate groups attached.


diadenosine tetraphosphate metabolic process

The chemical reactions and pathways involving diadenosine tetraphosphate, a derivative of the nucleoside adenosine with four phosphate groups attached.


nicotinamide nucleotide biosynthetic process from niacinamide

The chemical reactions and pathways resulting in the formation of nicotinamide nucleotide from other compounds, including niacinamide.


nucleotide salvage

Any process which produces a nucleotide, a compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety, from derivatives of it without de novo synthesis.


diadenosine hexaphosphate metabolic process

The chemical reactions and pathways involving diadenosine hexaphosphate.


The chemical reactions and pathways by which a purine deoxyribonucleotide is synthesized from another purine deoxyribonucleotide.


pyridine nucleotide salvage

Any process that generates a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base, from derivatives of them without de novo synthesis.


nucleoside bisphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a nucleoside bisphosphate, a compound consisting of a nucleobase linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


dAMP phosphorylation

The process of introducing a phosphate group into dAMP, deoxyadenosine monophosphate, to produce dADP. Addition of two phosphate groups produces dATP.


deoxyribonucleotide metabolic process

The chemical reactions and pathways involving a deoxyribonucleotide, a compound consisting of deoxyribonucleoside (a base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


purine deoxyribonucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine deoxyribonucleoside triphosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.


purine ribonucleoside triphosphate metabolic process

The chemical reactions and pathways involving purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.


XMP salvage

Any process which produces xanthosine monophosphate from derivatives of it, without de novo synthesis.


pyrimidine nucleoside diphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine nucleoside diphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.


purine deoxyribonucleoside monophosphate metabolic process

The chemical reactions and pathways involving purine deoxyribonucleoside monophosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with phosphate on the sugar.


pyridine nucleotide catabolic process

The chemical reactions and pathways resulting in the breakdown of a pyridine nucleotide, a nucleotide characterized by a pyridine derivative as a nitrogen base.


pyrimidine ribonucleotide catabolic process

The chemical reactions and pathways resulting in the breakdown of a pyrimidine ribonucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


pyrimidine deoxyribonucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine deoxyribonucleoside diphosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with diphosphate on the sugar.


cyclic nucleotide biosynthetic process

The chemical reactions and pathways resulting in the formation of a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.


pyrimidine deoxyribonucleoside diphosphate metabolic process

The chemical reactions and pathways involving pyrimidine deoxynucleoside diphosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with diphosphate on the sugar.


nucleotide catabolic process

The chemical reactions and pathways resulting in the breakdown of nucleotides, any nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the glycose moiety; may be mono-, di- or triphosphate; this definition includes cyclic-nucleotides (nucleoside cyclic phosphates).


pyrimidine deoxyribonucleotide metabolic process

The chemical reactions and pathways involving a pyrimidine deoxynucleotide, a compound consisting of nucleoside (a pyrimidine base linked to a deoxyribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.


purine nucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.


purine nucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine nucleoside triphosphate, a compound consisting of a purine base linked to a ribose or deoxyribose sugar esterified with triphosphate on the sugar.


pyrimidine deoxyribonucleoside monophosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine deoxynucleoside monophosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with phosphate on the sugar.


pyrimidine ribonucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine ribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with triphosphate on the sugar.


pyrimidine ribonucleoside diphosphate metabolic process

The chemical reactions and pathways involving pyrimidine ribonucleoside diphosphate, a compound consisting of a pyrimidine base linked to a ribose sugar esterified with diphosphate on the sugar.


ribonucleoside monophosphate metabolic process

The chemical reactions and pathways involving a ribonucleoside monophosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with phosphate on the sugar.


ribonucleoside bisphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


pyrimidine ribonucleotide salvage

The pathway by which pyrimidine bases or pyrimidine ribonucleosides from pyrimidine nucleotide breakdown are converted back to pyrimidine ribonucleotides. The salvage pathway is important where there is no de novo pyrimidine nucleotide biosynthesis.


deoxyribonucleoside diphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a deoxyribonucleoside diphosphate, a compound consisting of a nucleobase linked to a deoxyribose sugar esterified with diphosphate on the sugar.


purine nucleoside bisphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of a purine nucleoside bisphosphate, a compound consisting of a purine base linked to a deoxyribose or ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


ribonucleoside bisphosphate metabolic process

The chemical reactions and pathways involving a ribonucleoside bisphosphate, a compound consisting of a nucleobase linked to a ribose sugar esterified with one phosphate group attached to each of two different hydroxyl groups on the sugar.


cyclic nucleotide metabolic process

The chemical reactions and pathways involving a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.


pyrimidine nucleotide salvage

Any process which produces a pyrimidine nucleotide from derivatives of it, without de novo synthesis.


nicotinamide nucleotide biosynthetic process

The chemical reactions and pathways resulting in the formation of nicotinamide nucleotides, any nucleotide that contains combined nicotinamide.


nicotinate nucleotide biosynthetic process from tryptophan

The chemical reactions and pathways resulting in the formation of nicotinate nucleotide from other compounds, including tryptophan.


dCMP phosphorylation

The process of introducing a phosphate group into dCMP, deoxycytidine monophosphate, to produce dCDP. Addition of two phosphate groups produces dCTP.


pyrimidine nucleoside diphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of pyrimidine nucleoside diphosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with diphosphate on the sugar.


photosynthetic NADP+ reduction

An NADPH regeneration process that contributes to the light reactions of photosynthesis. The light reactions of photosynthesis use energy from photons to generate high-energy electrons. These electrons are used directly to reduce NADP+ to NADPH. NADPH is a relatively stable molecule and can pass on its hydrogen atom to other molecules in chemical reactions.


purine deoxyribonucleoside monophosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine deoxyribonucleoside monophosphate, a compound consisting of a purine base linked to a deoxyribose sugar esterified with phosphate on the sugar.


The chemical reactions and pathways by which a pyrimidine ribonucleotide is synthesized from another pyrimidine ribonucleotide.


purine ribonucleoside triphosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.


pyrimidine deoxyribonucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine deoxyribonucleoside triphosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with triphosphate on the sugar.


purine ribonucleoside diphosphate metabolic process

The chemical reactions and pathways involving purine ribonucleoside diphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with diphosphate on the sugar.


purine ribonucleoside monophosphate metabolic process

The chemical reactions and pathways involving purine ribonucleoside monophosphate, a compound consisting of a purine base linked to a ribose sugar esterified with phosphate on the sugar.


pyrimidine nucleoside monophosphate metabolic process

The chemical reactions and pathways involving pyrimidine nucleoside monophosphate, a compound consisting of a pyrimidine base linked to a ribose or deoxyribose sugar esterified with phosphate on the sugar.


pyrimidine deoxyribonucleoside diphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of pyrimidine deoxynucleoside diphosphate, a compound consisting of a pyrimidine base linked to a deoxyribose sugar esterified with diphosphate on the sugar.


purine ribonucleoside triphosphate catabolic process

The chemical reactions and pathways resulting in the breakdown of purine ribonucleoside triphosphate, a compound consisting of a purine base linked to a ribose sugar esterified with triphosphate on the sugar.


bis(5'-nucleosidyl) oligophosphate biosynthetic process

The chemical reactions and pathways resulting in the formation of a bis(5'-nucleosidyl) oligophosphate, a compound formed of two nucleosides joined together through their 5' carbons by a chain of phosphate molecules.


peptide serotonyltransferase activity

Catalysis of the reaction: L-glutaminyl-[protein] + serotonin = 5-serotonyl-L-glutamyl-[protein] + NH4(+).


GDP biosynthetic process

The chemical reactions and pathways resulting in the formation of GDP, guanosine 5'-diphosphate.


beta-microseminoprotein isoform hPSP94 (human)

A beta-microseminoprotein (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P08118-1.


leucine zipper transcription factor-like protein 1 isoform 1 (human)

A leucine zipper transcription factor-like protein 1 isoform 1 that is encoded in the genome of human.


gamma-aminobutyric acid receptor subunit beta-1

A GABA(A) receptor protein that is a translation product of the human GABRB1 gene or a 1:1 ortholog thereof.


gamma-aminobutyric acid receptor subunit beta-1, signal peptide removed form (human)

A gamma-aminobutyric acid receptor subunit beta-1 (human) that has had the signal peptide removed. UniProtKB:P18505, 26-474.


gamma-aminobutyric acid receptor subunit beta-1 isoform h2 (human)

A gamma-aminobutyric acid receptor subunit beta-1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P18505-2.


gamma-aminobutyric acid receptor subunit beta-1 isoform 1 (human)

A gamma-aminobutyric acid receptor subunit beta-1 isoform 1 that is encoded in the genome of human.


A protein that is a translation product of the human TSTD1 gene or a 1:1 ortholog thereof.


thiosulfate:glutathione sulfurtransferase isoform h2 (human)

A thiosulfate:glutathione sulfurtransferase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NFU3-2.


thiosulfate:glutathione sulfurtransferase isoform h1 (human)

A thiosulfate:glutathione sulfurtransferase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NFU3-1.


thiosulfate:glutathione sulfurtransferase isoform h4 (human)

A thiosulfate:glutathione sulfurtransferase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NFU3-4.


thiosulfate:glutathione sulfurtransferase isoform h3 (human)

A thiosulfate:glutathione sulfurtransferase (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q8NFU3-3.


RILP-like protein 1

A protein that is a translation product of the human RILPL1 gene or a 1:1 ortholog thereof.


RILP-like protein 1 isoform h3 (human)

A RILP-like protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5EBL4-3.


RILP-like protein 1 isoform h1 (human)

A RILP-like protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5EBL4-1.


RILP-like protein 1 isoform h2 (human)

A RILP-like protein 1 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q5EBL4-2.


fusion of virus membrane with host macropinosome membrane

Fusion of a viral membrane with a host macropinosome membrane, that occurs after internalization of the virus through the endosomal pathway, and results in release of the viral contents into the host cell cytoplasm.


negative regulation of acetylcholine secretion, neurotransmission

Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of acetylcholine.


N-acyl-D-amino-acid deacylase activity

Catalysis of the reaction: H2O + N-acyl-D-amino acid = D-amino acid + an acid.


protein NDRG3

A protein that is a translation product of the human NDRG3 gene or a 1:1 ortholog thereof.


protein NDRG3 isoform h2 (human)

A protein NDRG3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UGV2-2.


protein NDRG3 isoform 1 (human)

A protein NDRG3 isoform 1 that is encoded in the genome of human.


protein NDRG3 isoform h3 (human)

A protein NDRG3 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9UGV2-3.


vesicle transport through interaction with t-SNAREs homolog 1B isoform Long (human)

A vesicle transport through interaction with t-SNAREs homolog 1B isoform 1 that is encoded in the genome of human.


structural constituent of carboxysome shell

The action of a molecule that contributes to the structural integrity of a carboxysome shell, an organelle found in all cyanobacteria and some chemoautotrophs, consisting of a proteinaceous coat and enzymes for the fixation of CO2.


protein PRRC2C isoform h7 (human)

A protein PRRC2C (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q9Y520-7.


actin nucleation-promoting factor WAS, initiator methionine removed phosphorylated 1 (human)

An actin nucleation-promoting factor WAS (human) that has had the initiator methionine removed and that has been phosphorylated on the residue at the position equivalent to Tyr-291 of the amino acid sequence represented by UniProtKB:P42768. UniProtKB:P42768, 2-502, Tyr-291, MOD:00048.


cysteinyl leukotriene receptor

A leukotriene receptor that in active form binds cysteinyl leukotriene.


cysteinyl leukotriene receptor 1

A cysteinyl leukotriene receptor that is a translation product of the human CYSLTR1 gene or a 1:1 ortholog thereof. The preferred ligand is the cysteinyl leukotriene D4.


cysteinyl leukotriene receptor 2

A cysteinyl leukotriene receptor that is a translation product of the human CYSLTR2 gene or a 1:1 ortholog thereof. The preferred ligand is the cysteinyl leukotriene C4.


positive regulation of CD4 production

Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of CD4.


regulation of CD4 production

Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of CD4.


intracellular auxin homeostasis

A homeostatic process involved in the maintenance of a steady state level of auxin within a cell.


carbon catabolite repression of transcription from RNA polymerase II promoter by glucose

A transcription regulation process in which the presence of glucose leads to a decrease in the frequency, rate, or extent of transcription of specific RNA polymerase II-transcribed genes involved in the metabolism of other carbon sources. Carbon catabolite repression is a mechanism of genetic regulation which the accumulation of catabolites of one substance in the cell represses the formation of enzymes that contribute to the catabolism of other substances.


negative regulation of transcription by glucose

Any process involving glucose that decreases the frequency, rate or extent or transcription.


carbon catabolite repression of transcription by glucose

A transcription regulation process in which the presence of glucose leads to a decrease in the frequency, rate, or extent of transcription of specific genes involved in the metabolism of other carbon sources. Carbon catabolite repression is a mechanism of genetic regulation which the accumulation of catabolites of one substance in the cell represses the formation of enzymes that contribute to the catabolism of other substances.


endoplasmic reticulum aminopeptidase 2 isoform h3 (human)

An endoplasmic reticulum aminopeptidase 2 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:Q6P179-3.


C-Jun-amino-terminal kinase-interacting protein 4 isoform h6 (human)

A C-Jun-amino-terminal kinase-interacting protein 4 (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:O60271-9.


beta-chimaerin isoform h7 (human)

A beta-chimaerin (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P52757-7.


olfactory receptor 1S1

A class II olfactory receptor that is a translation product of the human OR1S1 gene or a 1:1 ortholog thereof.


keratin, type II cytoskeletal 2 oral

A protein that is a translation product of the human KRT76 gene or a 1:1 ortholog thereof.